While BPC-157 does not develop traditional tolerance, cycling remains common practice for several reasons including receptor sensitivity maintenance, cost management, and conservative approach given limited long-term human data
Anti-Doping Agency (USADA) confirm this regulatory position and do not permit compounding pharmacies to formulate BPC-157 medications
Journal of Chromatography A , 1265, 57-69
If you notice a sudden change in effectiveness, increased hunger, reduced appetite suppression, or stalled weight loss , and nothing else in your protocol has changed, degraded medication should be on your list of suspects
The Evolutionary History of the First Three Enzymes in Pyrimidine Biosynthesis